Compare Mattel Inc (MAT) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mattel Inc vs Novo Nordisk A/S — how do they compare? Mattel Inc trades at $15.03 (market cap $4.30B), while Novo Nordisk A/S trades at $45.89 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 48.3× Mattel Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Mattel Inc pays none. Which is the better fit depends on your goals.
| MAT | NVO | |
|---|---|---|
Market Cap | $4.30B | $207.85B |
Sector | Consumer Cyclical | Health |
52-Week High | $22.16 | $63.98 |
52-Week Low | $13.05 | $35.29 |
Enterprise Value | $6.52B | $222.55B |
Dividend Yield | — | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Mattel Inc
Mattel markets toy products that are sold to its wholesale customers and direct to retail consumers. The company offers products for children and families, including toys for infants and preschoolers, girls and boys, youth electronics, handheld and other games, puzzles, educational toys, media-driven products, and plush and fashion-related toys. Mattel's owned portfolio includes Barbie, Hot Wheels, Fisher-Price, Thomas & Friends, and American Girl. In addition, it currently manufactures toy products for its segments both internally and externally (through manufacturing partners). Just over half of its net sales are in North America, while the remainder stem from international markets.
Read more on MAT →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
